Search clinical trials for: Hematopoietic stem cell transplant (HSCT)

Total 66040 results

Alexion Pharmaceuticals

Withdrawn

Study in Adult and Pediatric Patients With HSCT-TMA

Thrombotic Microangiopathies | Stem Cell Transplant Complications

United States
IRCCS Burlo Garofolo

Completed

Gender Differences in Pediatric Hematopoietic Stem Cell Transplantation (HSCT)

Hematopoietic Stem Cell Transplantation
Zhi-Hong Liu, M.D.
Nanjing Medical University; Soochow University

Completed

Study of Bortezomib +HSCT in Primary Systemic Amyloidosis (AL)

Amyloidosis

China
Ospedale Santa Croce-Carle Cuneo

Unknown

Invasive Aspergillosis After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

Invasive Aspergillosis | Hematological Diseases

Italy
Orchard Therapeutics

Recruiting

A Study to Investigate the Efficacy and Safety of OTL-203 in Subjects With MPS-IH Compared With Standard of Care With Allogeneic HSCT (HURCULES)

MPS-IH (Hurler Syndrome)

Netherlands, United States, Italy, United Kingdom
Stanford University

Not yet recruiting

Aromatherapy Inhaler Use for HSCT Distress

Aromatherapy | Cancer Distress | Cancer Coping | Hematopoetic Stem Cell Transplant

United States
Micah Skeens
National Institute of Nursing Research (NINR)

Completed

Post-HSCT Medication Adherence mHealth App

Stem Cell Transplantation

United States
Ruijin Hospital

Not yet recruiting

The Efficacy of Allo-HSCT in ND HR-CBF-AML

Acute Myeloid Leukemia

China
Wuhan Union Hospital, China

Not yet recruiting

Moxibustion in the Treatment of Hemorrhagic Cystitis After Allo-HSCT

Hematopoietic Stem Cell Transplantation | Treatment | Hemorrhagic Cystitis | Moxibustion
Northwell Health

Completed

HSCT For Patients With High Risk Hemoglobinopathies Using Reduced Intensity

Sickle Cell Disease | Beta Thalassemia-Major

United States
Case Comprehensive Cancer Center

Withdrawn

Intervention for Caregivers of Patients Who Have Recently Undergone HSCT

Caregiver Distress | Caregiver Anxiety | Caregiver Health Related QOL
University of Florida
American Cancer Society, Inc.

Completed

Comparison of Gut Microbiota, Inflammation and Symptoms Following Allogeneic HSCT

Hematopoietic Stem Cell Transplantation | Graft vs Host Disease | Graft Versus Host Disease | Peripheral Blood Stem Cell Transplantation

United States
Nanfang Hospital of Southern Medical University
Sun Yat-sen University

Unknown

MSC for Treatment of Interstitial Lung Disease After Allo-HSCT

Lung Diseases, Interstitial | Bronchiolitis Obliterans | Hematopoietic Stem Cell Transplantation

China
Tehran University of Medical Sciences

Recruiting

Effectiveness of COVID-19 Vaccine in Hematopoietic Stem Cell Transplant Patients (ESCVHSCT)

COVID-19 Vaccines | Hematopoietic Stem Cell Transplantation (HSCT) | Immune System Tolerance

Iran, Islamic Republic of
University of Florida
Lallemand Bio-Ingredients

Terminated

Beta-glucan and Fatigue in HSCT Survivors

Autologous Haemopoietic Stem Cell Transplant

United States
Swedish Orphan Biovitrum
PRA Health Sciences; Cromsource; BioMérieux; Q2 Solutions; Cytel Inc.; ABF Pharmaceutical...

Terminated

Study to Investigate the Pharmacokinetics, Pharmacodynamics and Assess the Efficacy and Safety to Support Dose Selection of Emapalumab in Pre-empting Graft Failure in Patients at High Risk After HSCT.

Graft Failure

Canada, Australia, Israel
Chinese PLA General Hospital

Recruiting

Clinical Study of EBV-TCR-T Cells for EBV Infection After Allogenic HSCT

EBV Infection After Allogenic HSCT

China
City of Hope Medical Center

Terminated

Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron Overload

Primary Myelofibrosis | Stage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Iron Overload | Chronic Myelomonocytic Leukemia | Recurrent Adult Acute Myeloid Leukemia | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell... and other conditions

United States
Xiao-Jun Huang

Recruiting

CMV-TCR-T Cells for Refractory CMV Infection After HSCT

Allogeneic Hematopoietic Stem Cell Transplantation | CMV Infection

China
University Hospital, Basel, Switzerland

Recruiting

Expanded Natural Killer Cells Following Haploidentical HSCT for AML/MDS

Acute Myeloid Leukemia | Myelodysplastic Syndromes

Switzerland
Janssen Pharmaceutical K.K.

Completed

A Study of JNJ-26866138 (Bortezomib) in Untreated Multiple Myeloma Patients Who Are Not Candidates for Hematopoietic Stem Cell Transplant (HSCT)

Multiple Myeloma

Japan
Brigham and Women's Hospital

Recruiting

Peer Support Intervention for Patients Undergoing Hematopoietic Stem Cell Transplantation (STEPP)

Hematopoietic Malignancy | Hematopoietic Neoplasms

United States
Assistance Publique - Hôpitaux de Paris
Institut National de la Santé Et de la Recherche Médicale, France

Completed

Methyl-qPCR : a New Predictive Marker for Epstein-Barr Virus-associated Lymphoproliferations During Allogeneic Hematopoietic Stem Cell Transplantation (EBVALLO)

Hematologic Diseases | Allogeneic Disease | Epstein-Barr Viraemia

France
Massachusetts General Hospital

Completed

Supportive Care Intervention In Patients Hospitalized For Hematopoietic Stem Cell Transplantation (Shield) (SHIELD)

Complication of Transplant

United States
Institute of Hematology & Blood Diseases Hospital

Recruiting

A Study to Evaluate the Safety and Efficacy of COVID-19 Convalescent Plasma (CCP) Transfusion to Prevent COVID-19 in Adult Recipients Following Hematopoietic Stem Cell Transplantation

COVID-19 | Hematopoietic Stem Cell Transplantation

China
Nanfang Hospital of Southern Medical University

Unknown

Antibacterial Prophylaxis vs no Prophylaxis for Hematological Malignancies Patients Before Allo-HSCT

Hematological Malignancies | Imipenem | Antibacterial Prophylaxis | Allogenetic Hematopoietic Stem Cell Transplantation

China
Shanghai Children's Medical Center

Unknown

Fecal Microbiota Transplantation for Treatment of Refractory Graft Versus Host Disease-a Pilot Study

Fecal Microbiota Transplantation in GVHD
Nanfang Hospital of Southern Medical University
Peking University People's Hospital; Sun Yat-sen University; Guangzhou First... and other collaborators

Unknown

Mesenchymal Stem Cells Combined With Cord Blood for Treatment of Graft Failure

Mesenchymal Stem Cells | Hematopoietic Stem Cell Transplantation | Hematological Diseases | Graft Failure | Umbilical Cord Blood

China
Zhejiang University

Recruiting

Low-dose Chidamide Maintenance Therapy After Allo-HSCT for T-cell Acute Lymphoblastic Leukemia or T-cell Lymphomas

T Lymphoblastic Leukemia/Lymphoma

China
Hadassah Medical Organization

Unknown

Open-Label Study Designed to Evaluate the Safety and Preliminary Efficacy of ApoCell for the Prevention of Acute GvHD

Hematological Malignancies | Graft Versus Host Disease

Israel
Memorial Sloan Kettering Cancer Center
Weill Medical College of Cornell University

Completed

International Travel Patterns and Health Preparations of Hematopoietic Stem Cell Transplant Recipients at Memorial Sloan-Kettering Cancer Center

Hematopoietic Stem Cell Transplant

United States
Mats Remberger
The Swedish Research Council

Recruiting

Decidua Stroma Cells for Steroid Resistent Acute Graft-versus-host Disease After Allo-HSCT (2017-00355)

GVHD, Acute

Sweden, Norway, Denmark
Wuhan Union Hospital, China

Not yet recruiting

Moxibustion for the Prevention of Hemorrhagic Cystitis After Allo-HSCT

Hematopoietic Stem Cell Transplantation | Prevention | Hemorrhagic Cystitis | Moxibustion
University of Oslo

Recruiting

Brain Neuronal Networks, Chemosensory and Trigeminal Functions in Allo-HSCT

Hematopoietic Stem Cell Transplantation

Norway
Fujian Medical University

Recruiting

Co-transplantation of MSC in the Setting of Allo-HSCT

Allogeneic Hematopoietic Stem Cell Transplantation

China
Shanghai General Hospital, Shanghai Jiao Tong University...
Shanghai iCELL Biotechnology Co., Ltd, Shanghai, China

Completed

CMV-CTL for the Treatment of CMV Infection After HSCT

Cytomegalovirus Infections | Hematological Disease

China
Assiut University

Completed

Myths and Misconceptions About HSCT in a Limited Resource Region

Hematopoietic Stem Cell Transplantation

Egypt
Azienda Ospedaliera Città della Salute e della...

Completed

Physical Activity in Children During Hematopoietic Stem Cells Transplantation (HSCT)

Adolescent | Child | Hematopoietic Stem Cell Transplantation

Italy
Columbia University
Nemours Children's Clinic; Johns Hopkins All Children's Hospital

Completed

Probiotic Use in Children Undergoing Hematopoietic Stem Cell Transplantation (HSCT)

Hematopoietic Organs; Disorder

United States
Incyte Corporation

Approved for marketing

An Expanded Access Program of Ruxolitinib for the Treatment of Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplant

Graft-versus-host Disease (GVHD)

United States
Children's Hospital Medical Center, Cincinnati

Recruiting

TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients

Thrombotic Microangiopathies | Bronchiolitis Obliterans | Hematopoietic Stem Cell Transplant (HSCT) | Diffuse Alveolar Hemorrhage | Interstitial Pneumonitis

United States
University of Virginia

Completed

Effects of Prebiotics on Gut Microbiome in Patients Undergoing HSCT (HCTDiet)

Acute Myeloid Leukemia | Myelodysplastic Syndromes | Multiple Myeloma | Hodgkin Disease | Hodgkin Lymphoma | Myelofibrosis | Acute Lymphoblastic Leukemia | Mantle Cell Lymphoma | Sickle Cell Disease | Non Hodgkin Lymphoma | Acute Lymphocytic Leukemia | Myeloproliferative Neoplasm

United States
Massachusetts General Hospital
Dana-Farber Cancer Institute; Adienne SA

Withdrawn

Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplant (HSCT) For Lymphoma

Lymphoma

United States
Incyte Corporation

Approved for marketing

Expanded Access of Ruxolitinib Cream to Treat a Single Patient With cGVHD

Graft-versus-host Disease (GVHD)
Maria Sklodowska-Curie Memorial Cancer Center and...
Polish Adult Leukemia Group

Unknown

Personalized Therapy of Precursor Lymphoid Neoplasms

Precursor Lymphoid Neoplasms

Poland
Laurent Kaiser

Active, not recruiting

Blood Virome After Haploidentical Hematopoietic Stem Cell Transplantation, a Pilot Study

Haploidentical Hematopoietic Stem Cell Transplantation

Switzerland
Nanfang Hospital of Southern Medical University
Peking University People's Hospital; Sun Yat-sen University; Guangzhou First... and other collaborators

Unknown

Mesenchymal Stem Cells for Treatment of Poor Graft Function After Allogeneic Hematopoietic Stem Cell Transplant

Mesenchymal Stem Cells | Hematological Diseases | Stem Cell Transplantation, Hematopoietic | Poor Graft Function

China
Shanghai General Hospital, Shanghai Jiao Tong University...

Completed

Peg Interferon α-2b for Relapsed Hematological Malignancies After Allo-HSCT

Recurrence | Hematological Neoplasms

China
University Hospital Tuebingen
Ludwig-Maximilians - University of Munich; University Hospital Augsburg

Completed

Secondary Haplo HSCT for Relapse After Initial Allogeneic HSCT

Relapse of Hematological Malignancies
Celgene

Completed

Safety Study of Oral Azacitidine (CC-486) as Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Participants With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS).

Myelodysplastic Syndromes | Leukemia, Myeloid, Acute

United States, United Kingdom

Search clinical trials for: Hematopoietic stem cell transplant (HSCT)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Congo, DR of

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations